Showing results (131-140 of 149) with videos related to

Sort By:
Pageof 15
Journal of Thrombosis and Haemostasis : JTH|October 2, 2008
Reduction of the immune response to factor VIII mediated through tolerogenic factor VIII presentation by immature dendritic cellsM Qadura, M Othman, B Waters, et al.
Molecular Psychiatry|July 13, 2000
Association between the methylenetetrahydrofolate reductase 677C-->T missense mutation and schizophreniaR Joober, C Benkelfat, S Lal, et al.
Journal of Psychiatric Research|December 6, 2000
DRD3 and DAT1 genes in schizophrenia: an association studyR Joober, A Toulouse, C Benkelfat, et al.
Journal of Clinical Psychopharmacology|February 1, 1993
A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patientsG Chouinard, B Jones, G Remington, et al.
Archives of General Psychiatry|March 11, 2000
Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophreniaS E Purdon, B D Jones, E Stip, et al.
Annals of Biomedical Engineering|May 6, 2023
Dynamic Biophysical Cues Near the Tip Cell Microenvironment Provide Distinct Guidance Signals to Angiogenic NeovesselsAdam Rauff, Jason C Manning, James B Hoying, et al.
Journal of Clinical Psychopharmacology|August 5, 1998
A Canadian multicenter study of three fixed doses of controlled-release ipsapirone in outpatients with moderate to severe major depressionY D Lapierre, P Silverstone, R T Reesal, et al.
American Journal of Physiology. Heart and Circulatory Physiology|March 25, 2022
Matrix anisotropy promotes angiogenesis in a density-dependent mannerSteven A LaBelle, Shad S Dinkins, James B Hoying, et al.
Science Advances|September 16, 2020
Extracellular matrix compression temporally regulates microvascular angiogenesisM A Ruehle, E A Eastburn, S A LaBelle, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 7, 1998
Guidelines for depot antipsychotic treatment in schizophrenia. European Neuropsychopharmacology Consensus Conference in Siena, ItalyJ M Kane, E Aguglia, A C Altamura, et al.
Pageof 15